Palisade Bio (PALI) Debt Ratio (2010 - 2025)
Palisade Bio (PALI) reported Debt Ratio of 0.03 for Q3 2025, up 240.44% on a QoQ basis from 0.01 in Q2 2025.
Palisade Bio (PALI) has 11 years of Debt Ratio data on file, last reported at 0.03 in Q3 2025.
- Quarterly Debt Ratio changed N/A year-over-year to 0.03 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.03 (changed N/A YoY) and the FY2023 annual result came in at 0.01, changed N/A from the prior year.
- Debt Ratio grew to 0.03 in Q3 2025 per PALI's latest filing, from 0.01 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.08 in Q2 2021 and bottomed at 0.01 in Q4 2021.
- The 4-year median for Debt Ratio is 0.01 (2023), against an average of 0.02.
- The widest annual swing landed in 2021, when Debt Ratio slumped 98.16%; it then fell 14.49% in 2025.
- Tracing PALI's Debt Ratio over 4 years: stood at 0.01 in 2021, then jumped by 46.35% to 0.01 in 2023, then grew by 13.76% to 0.01 in 2024, then jumped by 191.12% to 0.03 in 2025.
- Per Business Quant, the three latest PALI Debt Ratio figures stand at 0.03 (Q3 2025), 0.01 (Q2 2025), and 0.01 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.05 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Jun 30, 2021 | 0.08 |
| Dec 31, 2020 | 0.38 |
| Mar 31, 2017 | 0.14 |
| Dec 31, 2016 | 0.16 |
| Sep 30, 2016 | 0.57 |
| Jun 30, 2016 | 0.44 |
| Mar 31, 2016 | 0.69 |
| Dec 31, 2015 | 0.53 |
| Sep 30, 2015 | 0.43 |
| Jun 30, 2015 | 0.34 |
| Mar 31, 2015 | 0.29 |
| Dec 31, 2014 | 0.29 |
| Sep 30, 2014 | 0.09 |
| Jun 30, 2014 | 0.20 |
| Mar 31, 2014 | 0.20 |
| Dec 31, 2013 | 0.40 |
| Sep 30, 2013 | 0.36 |
| Jun 30, 2013 | 0.55 |
| Mar 31, 2013 | 0.49 |
| Dec 31, 2010 | 0.12 |